When Red Laser Therapy Stops at the Skin

Superficial photobiomodulation, deeper near-infrared delivery, controlled thermal dosing.

A patient with Achilles tendon pain points to a very specific spot above the heel and says, “The laser feels warm, but the pain is still there when I walk.”

This is where a rehabilitation clinician has to stop thinking about the laser as simply a source of light.

The painful structure may be superficial enough to respond to red laser therapy, but the actual pathological tissue can sit deeper than the optical energy that reaches the surface would suggest. The clinician may increase treatment time, increase power, or move the handpiece more slowly, yet the patient can still experience the same pain during the activity that originally caused the problem.

The problem is not necessarily that photobiomodulation failed.

The problem may be that the wavelength and energy-delivery strategy were not matched to the depth of the target.

This distinction matters when a clinic is comparing a simple red-light device with a professional laser light therapy machine. A 650 nm treatment can have a useful role in superficial tissue, while 810 nm, 915 nm, 940 nm, and 980 nm provide other options when the target becomes deeper or when the clinician needs a different balance between penetration, absorption, thermal response, and total energy.

FotonMedix’s LaserMedix-MAX is built around this broader treatment concept. The system combines 650 nm, 810 nm, 915 nm, 940 nm, and 980 nm with a stated 30 W output, temperature indication, hot and cold functions, and a claimed tissue penetration capability of up to 15 cm.

For a clinic treating pain, the useful question is therefore not simply whether red light works.

It is which wavelength should be doing the work at which tissue depth.

The Patient Does Not Feel Photon Penetration

One of the easiest mistakes in laser treatment is using the patient’s sensation as a proxy for treatment depth.

The patient feels warmth.

The clinician assumes the tissue underneath is receiving a strong dose.

That assumption is unreliable.

The sensation of warmth is generated primarily by tissue heating near the treatment path. It tells the operator something about local thermal response, but it does not directly reveal how much optical energy remains concentrated at a tendon, joint capsule, muscle belly, or deeper inflammatory structure.

Light traveling through biological tissue is continuously affected by absorption and scattering.

Absorption transfers optical energy into tissue chromophores.

Scattering changes photon direction.

The result is a progressive reduction in useful irradiance as depth increases.

This is why the same amount of energy displayed by the machine at the treatment surface cannot be assumed to reach a structure several centimeters below the skin.

For red laser therapy, this is particularly relevant because visible red wavelengths are strongly affected by superficial tissue.

A superficial target may be completely appropriate.

A deep target may require a different wavelength.

Why 650 nm Can Be Useful Without Being a Deep-Tissue Wavelength

Red wavelengths around 650 to 660 nm are widely used in photobiomodulation research.

They can interact with superficial tissue and are associated with biological responses involving cellular signaling, inflammation, pain modulation, and tissue repair.

But the clinical value of 650 nm should not be confused with unlimited penetration.

The wavelength is visible red light.

As it travels through skin and other tissue, scattering and absorption reduce the amount of concentrated energy remaining at increasing depth.

This creates a very practical distinction.

A clinician treating superficial peri-tendinous tissue may have a good reason to use red light.

A clinician treating a deeper portion of the Achilles tendon may need to introduce near-infrared wavelengths.

The two approaches do not compete.

They can be layered.

FotonMedix includes 650 nm as the shortest wavelength in the five-wavelength LaserMedix-MAX configuration, alongside four near-infrared wavelengths.

That configuration is more clinically flexible than a machine limited to red light alone.

The Evidence for Red and Near-Infrared Photobiomodulation Is More Nuanced Than Marketing Suggests

The clinical literature does not support the idea that every pain condition will respond to one wavelength or one fixed dose.

A 2021 systematic review and meta-analysis evaluated 17 randomized trials involving 835 participants with tendinopathy. The authors found that photobiomodulation combined with exercise produced greater reductions in pain and improvements in function than sham treatment combined with exercise, but the overall certainty of evidence ranged from very low to moderate depending on the outcome and comparison.

That is an important finding for clinical practice.

Photobiomodulation may be useful as an adjunct.

Exercise remains important.

The laser does not repair a dysfunctional movement pattern by itself.

It does not replace progressive loading.

It does not eliminate the need for diagnosis.

Instead, it can become part of a treatment sequence in which pain modulation and tissue stimulation make active rehabilitation easier to perform.

A 2024 systematic review and meta-analysis of photobiomodulation for knee osteoarthritis reached a similarly cautious conclusion. Across 10 studies involving 542 participants, PBM reduced pain intensity and may improve disability, but the authors judged the certainty of evidence to be very low and did not recommend isolated PBM as a replacement for established therapies.

That is a much more useful way to understand laser light therapy pain treatment.

It is not about promising that the machine “cures pain.”

It is about determining where controlled optical energy can fit into a broader clinical protocol.

A Common Tendon Problem Shows Why Wavelength Selection Matters

Consider an office worker who develops chronic Achilles tendon pain.

The pain is not located directly on the skin.

The clinician can palpate the tendon.

The patient can identify the painful area.

But the tendon is not a flat surface target.

The tendon has thickness.

The tissue may have degenerative changes.

There may be localized neovascularization, altered extracellular matrix, thickening, and changes in mechanical loading.

The patient feels pain during walking and especially during the first few minutes after getting out of bed.

A red-light-only treatment can be reasonable for superficial tissue.

But if the goal is to influence deeper portions of the tendon, the clinician needs to think about optical depth.

This is where near-infrared wavelengths become more relevant.

The treatment can move from a superficial photobiomodulation concept toward a deeper energy-delivery strategy.

810 nm Changes the Optical Path

Around 810 nm, the treatment moves into the near-infrared region.

Compared with visible red light, near-infrared wavelengths are generally better suited to delivering useful optical energy deeper into tissue under many clinical conditions.

That does not mean that 810 nm simply travels through tissue without attenuation.

It still encounters absorption and scattering.

But its optical interaction profile makes it a common choice in deeper photobiomodulation research.

The clinical literature includes studies using wavelengths around 808 to 830 nm for tendon, joint, and postoperative applications. A 2026 systematic review of near-infrared therapy for surgical wound healing found that protocols using shorter near-infrared wavelengths in the 700 to 850 nm range were among those associated with favorable outcomes, although the authors emphasized that certainty of evidence remained very low and protocols varied considerably.

That variation is important.

There is no single “correct” laser setting for every patient.

The wavelength is only one part of the treatment.

915 nm and 940 nm Add More Options

The intermediate near-infrared wavelengths of 915 nm and 940 nm are particularly interesting when a system is designed for broader tissue interaction rather than a single wavelength.

Their absorption characteristics differ from both 650 nm and 810 nm.

As wavelength increases through the near-infrared region, the relative contribution of water and blood absorption changes.

This means that the clinician is not simply choosing a number.

The clinician is selecting an optical interaction profile.

That becomes valuable when treating different anatomical structures.

A superficial soft-tissue complaint may justify one wavelength.

A thick muscle region may justify another.

A tendon may require another combination.

A deeper joint target may need a higher-energy near-infrared protocol.

This is the reason a multi-wavelength laser light therapy machine can be more useful in a multidisciplinary clinic.

980 nm Has a Different Thermal and Absorption Profile

980 nm deserves separate attention because it sits near a region where both water and hemoglobin absorption contribute to tissue interaction.

It is therefore useful in high-intensity laser applications where the clinician wants substantial energy delivery while also managing thermal response.

The important point is not that 980 nm is automatically better.

It is that it behaves differently.

At 1470 nm, water absorption becomes much stronger, making that wavelength particularly relevant in surgical applications involving water-rich tissue.

At 980 nm, the balance is different.

This creates a practical option for high-intensity therapy where deeper delivery and controlled photothermal effects are part of the treatment strategy.

FotonMedix’s LaserMedix-MAX includes 980 nm as the longest wavelength in its five-wavelength therapeutic configuration.

For a B2B buyer, the significance is that one platform can provide both visible red and multiple near-infrared options.

The Real Problem Is Often Energy Distribution

A clinician may say:

“I delivered 5,000 joules.”

That sounds precise.

But total joules alone do not tell the whole clinical story.

Where was the energy delivered?

Over what area?

At what power?

For how long?

With what duty cycle?

At which wavelength?

Was the handpiece stationary or moving?

How thick was the tissue?

What was the patient’s thermal response?

These variables change the treatment substantially.

For example, 5,000 J delivered across a large treatment area is very different from 5,000 J concentrated into a small trigger point.

Likewise, 5,000 J delivered continuously is not thermally equivalent to 5,000 J delivered with a controlled duty cycle.

The same total energy can produce different tissue responses because the temporal and spatial distribution is different.

That is why a professional laser light therapy machine should give the operator control over multiple parameters rather than only total treatment time.

Duty Cycle Determines How High Energy Behaves

This becomes especially important when the clinic uses a Class IV high-intensity platform.

High peak power can shorten treatment time.

But high peak power also increases the rate at which heat can accumulate in superficial tissue.

If the clinician simply applies high power continuously, the patient may become uncomfortable before the desired deep-tissue exposure is achieved.

The operator then has to reduce power.

Treatment efficiency falls.

Duty cycle offers another option.

A pulsed protocol can deliver high instantaneous power during the active portion of the cycle while allowing periods of reduced emission.

This gives tissue time to dissipate part of the accumulated heat.

It does not eliminate thermal risk.

It does not make unlimited energy safe.

It simply gives the clinician another method for controlling the relationship between peak output and average thermal exposure.

FotonMedix positions LaserMedix-MAX around high-energy PBM with temperature indication and treatment-depth technology, while its veterinary platform also specifies Super Pulse operation and adjustable thermal sensation.

The underlying clinical principle is straightforward.

The highest available power should be treated as an operating range, not as a mandatory treatment setting.

A Simulated Tendon Clinic Case

Der folgende Fall ist ein simulated clinical case for treatment-protocol illustration rather than a claimed real patient record.

The structure is based on the clinical literature concerning red and near-infrared photobiomodulation for tendinopathy and on the parameter-control capabilities of professional high-intensity laser systems.

Case Registration

Klinischer Punkt	Case Data
ID des simulierten Falls	FM-SPT-AT-026-052
Alter des Patienten	52 years
Sex	Männlich
Abteilung	Sport-Physiotherapie
Primärdiagnose	Chronic mid-portion Achilles tendinopathy
Symptom Duration	11 months
Baseline Activity	Walking and recreational tennis
Baseline Pain	7/10 during first steps in the morning
Activity Pain	8/10 after prolonged walking
Ertasten	Localized mid-portion Achilles tenderness
Functional Limitation	Unable to complete normal tennis session
Imaging Context	Tendon thickening without acute rupture
Treatment Objective	Pain modulation and improved tolerance to progressive loading
Adjunct Treatment	Calf strengthening and progressive tendon loading
Behandlungsdauer	6 Wochen
Planned Sessions	12

Simulated Laser Protocol

Behandlungsphase	Sitzungen	650 nm	810 nm	980 nm	Strom	Frequenz	Einschaltdauer	Energie insgesamt
Superficial preparation	1–2	40%	60%	—	8 W	500 Hz	30%	1,500 J
Early pain control	3–4	30%	70%	—	12 W	1.000 Hz	35%	2,200 J
Deeper tendon phase	5-8	20%	60%	20%	18 W	1.000 Hz	40%	3,600 J
High-energy loading phase	9–10	10%	50%	40%	22 W	500 Hz	50%	4,400 J
Recovery phase	11–12	30%	70%	—	12 W	1.000 Hz	30%	2,000 J

These numbers are not a prescription and should not be transferred directly to patients.

They illustrate a more important concept.

The treatment starts with a greater contribution from 650 nm and 810 nm.

As the clinical target becomes more focused on deeper tendon tissue, the proportion of near-infrared exposure increases.

During the higher-energy phase, 980 nm is introduced.

Once the patient’s symptoms and loading tolerance improve, the total treatment load is reduced again.

The protocol therefore follows the clinical phase rather than keeping the machine at one fixed setting for every appointment.

Simulated Clinical Progression

Ergebnis	Basislinie	Woche 2	Woche 3	Woche 4	Woche 5	Woche 6
Morning pain	7/10	5/10	4/10	3/10	2/10	2/10
Walking pain	8/10	6/10	5/10	4/10	3/10	2/10
First-step stiffness	20 min	15 min	12 min	8 min	5 min	4 min
Single-leg heel raises	8	12	15	20	25	30
Walking tolerance	30 min	40 min	50 min	60 min	75 min	90 min
Tennis participation	Unmöglich	Unmöglich	Light drills	20 min	35 min	45 min
Post-treatment heat discomfort	—	Mild	Mild	Mäßig	Mild	Minimal

Again, these values are simulated.

The clinical lesson is that pain should not be the only outcome.

If the patient reports VAS improvement but still cannot perform a heel raise, the treatment plan is incomplete.

If pain decreases while loading tolerance increases, the clinician has a more meaningful functional signal.

Why Exercise Still Matters in the Laser Protocol

Tendinopathy is a good example of why laser should not be treated as an isolated solution.

The tendon is a mechanical structure.

Its ability to tolerate load matters.

A patient may feel less pain after a laser session while the tendon remains mechanically deconditioned.

That is why progressive loading remains a major part of tendinopathy management.

The 2021 systematic review found that PBM combined with exercise produced greater improvements than sham plus exercise in its pooled comparison, while PBM did not clearly outperform other active interventions when both were combined with exercise.

That finding fits the practical treatment-room experience.

The laser may help the patient tolerate the rehabilitation session.

The exercise provides the mechanical stimulus.

The clinician monitors both.

This is a much more credible use of laser light therapy pain treatment than telling the patient that the laser itself will rebuild the tendon.

Red Laser Therapy Can Be Useful Before the Deeper Treatment

There is another practical reason to retain the 650 nm wavelength.

Not every treatment needs to begin with maximum penetration.

The superficial tissues can contribute to pain sensitivity.

The patient may have local tenderness around the tendon sheath, fascia, skin, and subcutaneous tissue.

Treating the superficial component first can be useful for patient comfort and may allow the clinician to progress into the deeper treatment phase without immediately applying a high thermal load.

This is especially useful for patients who are sensitive to heat.

The operator can establish a controlled response.

Then the treatment can move deeper.

This layered concept is one of the stronger arguments for a multi-wavelength platform.

What Happens When the Clinician Uses Too Much Power

Imagine the operator applies 25 W continuously to a small Achilles treatment area.

The patient feels strong heat after one minute.

The operator reduces power.

The patient still feels discomfort.

The clinician ends the treatment.

The problem is not that the machine lacks power.

The problem is that the treatment was limited by superficial thermal accumulation.

This is the opposite of the intended result.

The machine had enough energy.

The clinician could not deliver it efficiently.

A controlled pulsed protocol may provide a better balance.

The handpiece can move.

The duty cycle can change.

The treatment area can be expanded.

The wavelength can be adjusted.

The total energy can remain clinically appropriate without forcing the patient to tolerate excessive surface heat.

This is why a high-power laser should be viewed as a controllable energy-delivery system, not as a heater.

Why a Laser Light Therapy Machine Is More Than a Red-Light Device

A consumer red-light device generally answers one question.

“How much red or near-infrared light can I expose the body to?”

A professional clinical laser system answers several questions.

“What tissue am I treating?”

“How deep is the target?”

“What wavelength should I use?”

“How much energy should I deliver?”

“How quickly should I deliver it?”

“How much heat is accumulating?”

“How should the protocol change when the patient improves?”

That is a different workflow.

LaserMedix-MAX offers five wavelengths from 650 nm through 980 nm and a stated 30 W output. FotonMedix also specifies temperature indication, depth-maintaining technology, and dual hot and cold treatment functions.

For a physiotherapy department, that means one platform can be configured around different anatomical targets instead of requiring separate equipment for every treatment depth.

Why a Clinic Should Not Buy Only for the Keyword Red Laser Therapy

Patients often search using simple language.

They search:

“red laser therapy”

“laser light therapy pain”

“laser light therapy machine”

But the clinical equipment decision is more complicated.

A patient may think red light is the treatment.

The clinician needs to think about wavelength.

A procurement manager needs to think about treatment range.

A distributor needs to think about clinical indications, training, serviceability, safety, and market positioning.

The search term is simple.

The equipment requirement is not.

This is why medical laser manufacturers should explain the clinical logic behind the wavelengths rather than simply listing them.

Five Questions to Ask Before Purchasing a Laser Light Therapy Machine

Can It Treat More Than One Tissue Depth?

A clinic that treats only superficial conditions may have limited requirements.

A multidisciplinary rehabilitation center needs more flexibility.

Can the Operator Change Wavelengths?

A multi-wavelength platform gives clinicians more options when the anatomical target changes.

Can Power Be Controlled Precisely?

Maximum output matters less than the usable range.

The clinician needs enough power for deeper treatment but also needs lower settings for sensitive areas.

Can the System Control Pulse Structure?

Pulse frequency and duty cycle become important when high-energy treatment creates thermal limitations.

Can Temperature Be Monitored?

Patient comfort is part of treatment efficiency.

If excessive heat repeatedly forces the clinician to stop, the machine’s theoretical output becomes irrelevant.

The Commercial Difference Between a Red Laser and a Multi-Wavelength Class IV System

For a B2B buyer, the distinction can be summarized very simply.

A red laser system may be appropriate when the clinic’s primary demand is superficial photobiomodulation.

A multi-wavelength Class IV system can address a wider range of treatment depths and clinical workflows.

LaserMedix-MAX provides five wavelengths and 30 W output, while FotonMedix’s veterinary VetMedix-MAX extends the same five-wavelength architecture into a 38 W peak-power veterinary platform with Super Pulse, temperature indication, and dual hot and cold functions.

This matters for distributors serving hospitals, physiotherapy clinics, sports rehabilitation centers, and veterinary practices.

The equipment can be positioned around the broader concept of high-energy photobiomodulation rather than being restricted to one superficial red-light application.

The Clinical Evidence Supports a Complementary Role

The current evidence does not justify replacing established rehabilitation with light therapy.

The 2024 knee osteoarthritis meta-analysis found pain reduction but rated the certainty of evidence very low and concluded that PBM should not be used as an isolated replacement for widely recommended therapies.

The tendinopathy meta-analysis found the strongest signal when PBM was combined with exercise rather than used as a replacement for active rehabilitation.

This is actually good news for a serious medical laser business.

It creates a clinically responsible position.

The laser becomes an adjunct.

The clinician retains control.

The patient still receives diagnosis and rehabilitation.

The equipment adds another treatment modality rather than making unrealistic promises.

Red Laser Therapy Versus Deeper Laser Treatment in the Same Room

A useful rehabilitation workflow might look like this.

A patient arrives with Achilles tendon pain.

The clinician examines the tendon and confirms that there is no acute rupture requiring another treatment pathway.

The superficial region is treated with a lower-energy red component.

The near-infrared wavelength is then introduced for the deeper tendon target.

The clinician adjusts treatment movement and pulse structure according to thermal sensation.

The patient performs progressive loading afterward.

At the next visit, the clinician records pain, morning stiffness, heel-raise capacity, walking tolerance, and treatment response.

If function improves, the laser dose can be reduced.

If pain remains high, the clinician reassesses the diagnosis rather than simply increasing the power.

This last point is important.

When a treatment fails, increasing the laser power should not always be the first response.

The diagnosis may be wrong.

The target may be wrong.

The wavelength may be wrong.

The dose may be wrong.

The treatment area may be wrong.

Or the patient may require a different clinical intervention.

That is what distinguishes professional laser treatment from trial-and-error heat application.

Final Clinical Perspective

Red laser therapy remains useful because superficial photobiomodulation has a legitimate place in clinical rehabilitation.

But the visible red wavelength is not a universal answer to every pain problem.

When the target becomes deeper, the clinician has to account for optical attenuation.

Scattering changes photon direction.

Absorption removes energy from the propagating beam.

Tissue composition changes the treatment response.

The amount of energy reaching a tendon or joint therefore depends on much more than the number displayed on the laser.

A 650 nm wavelength can serve the superficial treatment layer.

An 810 nm wavelength can extend the strategy toward deeper tissue.

915 nm and 940 nm provide additional near-infrared options.

980 nm provides another high-energy treatment profile with different absorption characteristics.

Power determines how quickly energy is delivered.

Frequency changes the temporal pattern.

Duty cycle determines the proportion of time the system is actively emitting.

Treatment movement determines how energy is distributed spatially.

Temperature monitoring helps keep patient comfort from becoming the limiting factor.

The clinical literature supports a cautious but useful role for photobiomodulation. Tendinopathy research suggests that PBM can provide additional benefit when combined with exercise, while the 2024 knee osteoarthritis meta-analysis found pain reduction but emphasized the low certainty of evidence and the need for PBM to complement rather than replace established care.

For a clinic considering a Laser-Licht-Therapie-Gerät, this is the key distinction.

Do not buy a system simply because it produces red light.

Buy according to the clinical problems you actually need to treat.

If your patients mainly have superficial complaints, red wavelengths may be valuable.

If your clinic treats tendons, muscles, joints, sports injuries, and deeper pain conditions, a broader wavelength range gives the clinician more room to build tissue-specific protocols.

FotonMedix’s LaserMedix-MAX combines 650 nm, 810 nm, 915 nm, 940 nm, and 980 nm in a 30 W Class IV platform, with temperature indication and depth-maintaining technology designed around high-energy PBM.

That approach changes the conversation from “Does red laser therapy work?”

to a much better clinical question:

Which wavelength, energy level, pulse structure, and treatment depth are appropriate for this patient’s actual pain source?

Für Laserlichttherapie bei Schmerzen applications, that is where the value of a professional system becomes clear.

The goal is not maximum heat.

It is not maximum wattage.

It is not simply making the patient feel the laser.

The goal is controlled energy delivery to the appropriate tissue, followed by measurable functional rehabilitation.

That is the difference between treating the skin over a painful structure and treating the clinical problem underneath it.